Early research (Phase 1)Ended earlyNCT05156905
What this trial is testing
Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of California, San Diego 6